Thomas Davis
Executive Vice President and Chief Medical Officer
Clinical Development
Celldex Therapeutics
United States of America
Biography
Dr. Davis is Executive Vice President and Chief Medical Officer of Celldex. Prior to this appointment in 2014, he was Senior Vice President of Clinical Development and Chief Medical Officer of Celldex. Formerly he was Chief Medical Officer at GenVec and Senior Director of Clinical Science at Medarex. He has supervised clinical efforts in adult hematologic malignancies and marrow transplantation and therapeutic antibodies and vaccines at the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI) and worked with Dr. Ron Levy on the development of rituximab and idiotype vaccines at Stanford University. Dr. Davis received his B.A. in Biophysics from Johns Hopkins, M.S. in Physiology and M.D. from Georgetown University, and Oncology training at Stanford University.
Research Interest
development of rituximab and idiotype vaccines ,marrow transplantation and therapeutic antibodies
